Advertisement
Advertisement
September 22, 2019
Baylis Medical's All-in-One VersaCross Transseptal Solution Used in MitraClip Procedure
September 23, 2019—Baylis Medical Company, Inc. announced the first MitraClip procedure performed using the company’s VersaCross transseptal solution. The procedure was performed by William A. Gray, MD, who is System Chief of Cardiovascular Diseases for Main Line Health and President of Lankenau Heart Institute in Wynnewood, Pennsylvania.
According to the company, the VersaCross solution is an all-in-one left heart access device featuring an atraumatic radiofrequency-tipped pigtail wire. The device is designed to achieve left heart access with controlled precision while reducing the number of exchanges throughout the procedure by serving as an exchange wire once access is achieved.
The puncture wire features Baylis Medical’s radiofrequency puncture technology, which aims to facilitate smooth and precise transseptal procedures. The VersaCross solution also includes a shapeable sheath and dilator, further allowing transseptal punctures to occur at the optimal location on the septum.
Additionally, the company noted that the VersaCross solution has a sturdy 0.035-inch exchange rail, eliminating the need for additional devices to achieve reliable delivery of large sheaths. It facilitates efficient transseptal procedures by reducing the overall number of device exchanges. The VersaCross platform is also available in a J-tip wire and can be paired with a range of sheaths tailored to individual needs. Baylis Medical expects to launch the device in early 2020.
Dr. Gray commented in the company’s press release, “Structural heart procedures requiring transseptal approaches demand a very precise puncture location to optimize therapy delivery. Traditionally, this requires the use of multiple devices in a stepwise method. If the optimal location is not achieved on first pass, we are required to return to the starting point, which involves the time consuming and potentially riskier reintroduction of multiple devices. This new device enables a novel technique which minimizes the need for exchanges and streamlines transseptal access while achieving the optimal puncture location.”
Advertisement
Advertisement